-
Hymon® Clopidogrel-Resistance Gene Polymorphism Detection Kit
This kit uses RT-PCR for in vitro detection of CYP2C9*2, *3, and *17 polymorphism associated with clopidogrel resistance in peripheral blood, identify gene polymorphism between different patients and provide the basis for individualized clopidogrel medication.
The test uses specific gene sequences as PCR target regions. Human genomic sequence is used as internal quality control.
-
Hymon® Neural Tube Defect Gene Polymorphism Detection Kit
This kit uses RT-PCR for detecting MTHFR 677C>T, 1298(A>C), and MTRR66A>G polymorphism in peripheral blood, identify gene polymorphism between different patietns and provide the basis for individualized nitroglycerin medication.
The test uses specific gene sequences as PCR target regions. Human genomic sequence is used as internal quality control.
-
Hymon® Metabolic Enzyme Gene Polymorphism Detection Kit
This kit uses RT-PCR for in vitro detection of APOE 338T>C, 526C>T, SLCO1B1 388A>G, and 521T>C polymorphism in peripheral blood, identify gene polymorphism between different patients and provide the basis for individualized nitroglycerin medication.
The test uses specific gene sequences as PCR target regions. Human genomic sequence is used as internal quality control.
-
Hymon® ALDH2 Gene Polymorphism Detection Kit
This kit uses RT-PCR for in vitro detection of ALDH2*2 (1510G>A) gene polymorphism in peripheral blood, identify gene polymorphism between different patients and provide the basis for individualized nitroglycerin medication.
The test uses specific gene sequences as PCR target regions. Human genomic sequence is used as internal quality control.
-
Hymon® Warfarin Metabolic Enzyme Gene Polymorphism Detection Kit
This kit uses RT-PCR for in vitro detection of polymorphisms of CYP2C9*2 (C430T), CYP2C9*3 (A1075C), and VKORC1 site-1639 (G>A) associated with warfarin metabolism in peripheral blood.
Based on test results, appropriate initial dosage of warfarin for patients with different genotypes to obtain timely individualized treatment plans.
The test uses specific gene sequences as PCR target regions. HUman genomic sequence is used as internal quality control.
